Ultragenyx Pharmaceutical | RARE - Текущие обязательства





Текущие обязательства Изменить Дата
Acadia Pharmaceuticals USD 277.11M 79.47M 2025-12
Agios Pharmaceuticals USD 58.84M 23.36M 2026-03
Alnylam Pharmaceuticals USD 1.35B 116.87M 2026-03
BioCryst Pharmaceuticals USD 196.07M 5.83M 2025-12
BioMarin Pharmaceutical USD 759.03M 39.41M 2025-12
Esperion Therapeutics USD 300.81M 58.22M 2025-12
Immunic USD 30.62M 539K 2025-12
Insmed USD 468.87M 51.66M 2025-12
Ionis Pharmaceuticals USD 717M 66M 2026-03
Karyopharm Therapeutics USD 92.06M 4.9M 2025-12
Kyowa Hakko Kirin JPY 181.08B 4.08B 2025-12
MacroGenics USD 43.11M 1.36M 2025-12
Moderna USD 1.99B 306M 2025-12
Neurocrine Biosciences USD 743.4M 105.4M 2025-12
PTC Therapeutics USD 968.43M 102.18M 2025-12
Puma Biotechnology USD 82.73M 3.63M 2025-09
Regeneron Pharmaceuticals USD 5.11B 739.3M 2026-03
Sarepta Therapeutics USD 1.1B 173.86M 2025-12
Ultragenyx Pharmaceutical USD 340.02M 46.78M 2025-09
Vertex Pharmaceuticals USD 3.86B 614.1M 2025-12
Xoma USD 28.3M 6.81M 2025-09